Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Goletti

Showing results (121-130 of 310) with videos related to

Pageof 31
Sort By:
Biomed Research International|September 9, 2015
Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in ChildrenLinda Petrone, Angela Cannas, Francesco Aloi, et al.
European Journal of Clinical Investigation|November 27, 2022
Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10-year study from the BIOPURE registryMarco Fornaro, Stefano Stano, Delia Goletti, et al.
Immunology Letters|June 9, 2015
Granzyme A as a potential biomarker of Mycobacterium tuberculosis infection and diseaseGiuliana Guggino, Valentina Orlando, Stella Cutrera, et al.
Frontiers in Medicine|March 15, 2024
B-cell-depleted patients with persistent SARS-CoV-2 infection: combination therapy or monotherapy? A real-world experienceAlessandra D'Abramo, Serena Vita, Alessia Beccacece, et al.
Molecular Medicine (Cambridge, Mass.)|July 17, 2003
Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosisDonatella Vincenti, Stefania Carrara, Patrizia De Mori, et al.
Immunology Letters|April 11, 2018
Impact of antiretroviral and tuberculosis therapies on CD4<sup>+</sup> and CD8<sup>+</sup> HIV/M. tuberculosis-specific T-cell in co-infected subjectsTeresa Chiacchio, Elisa Petruccioli, Valentina Vanini, et al.
IJID Regions|April 9, 2025
Global perspectives on tuberculosis in prisons and incarceration centers - Risk factors, priority needs, challenges for control and the way forwardPeter S Nyasulu, David S Hui, Peter Mwaba, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 4, 2017
The global dynamics of diabetes and tuberculosis: the impact of migration and policy implicationsEnrico Girardi, Monica Sañé Schepisi, Delia Goletti, et al.
Plos Neglected Tropical Diseases|April 12, 2023
Antigen discovery by bioinformatics analysis and peptide microarray for the diagnosis of cystic echinococcosisGherard Batisti Biffignandi, Ambra Vola, Davide Sassera, et al.
Biomedicines|May 27, 2023
SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital PersonnelAnnapaola Santoro, Andrea Capri, Daniele Petrone, et al.
Pageof 31

Showing results (121-130 of 310) with videos related to

Sort By:
Pageof 31
Biomed Research International|September 9, 2015
Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in ChildrenLinda Petrone, Angela Cannas, Francesco Aloi, et al.
European Journal of Clinical Investigation|November 27, 2022
Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10-year study from the BIOPURE registryMarco Fornaro, Stefano Stano, Delia Goletti, et al.
Immunology Letters|June 9, 2015
Granzyme A as a potential biomarker of Mycobacterium tuberculosis infection and diseaseGiuliana Guggino, Valentina Orlando, Stella Cutrera, et al.
Frontiers in Medicine|March 15, 2024
B-cell-depleted patients with persistent SARS-CoV-2 infection: combination therapy or monotherapy? A real-world experienceAlessandra D'Abramo, Serena Vita, Alessia Beccacece, et al.
Molecular Medicine (Cambridge, Mass.)|July 17, 2003
Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosisDonatella Vincenti, Stefania Carrara, Patrizia De Mori, et al.
Immunology Letters|April 11, 2018
Impact of antiretroviral and tuberculosis therapies on CD4<sup>+</sup> and CD8<sup>+</sup> HIV/M. tuberculosis-specific T-cell in co-infected subjectsTeresa Chiacchio, Elisa Petruccioli, Valentina Vanini, et al.
IJID Regions|April 9, 2025
Global perspectives on tuberculosis in prisons and incarceration centers - Risk factors, priority needs, challenges for control and the way forwardPeter S Nyasulu, David S Hui, Peter Mwaba, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 4, 2017
The global dynamics of diabetes and tuberculosis: the impact of migration and policy implicationsEnrico Girardi, Monica Sañé Schepisi, Delia Goletti, et al.
Plos Neglected Tropical Diseases|April 12, 2023
Antigen discovery by bioinformatics analysis and peptide microarray for the diagnosis of cystic echinococcosisGherard Batisti Biffignandi, Ambra Vola, Davide Sassera, et al.
Biomedicines|May 27, 2023
SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital PersonnelAnnapaola Santoro, Andrea Capri, Daniele Petrone, et al.
Pageof 31